Adriamycin RTU 10 mg Injection

About Adriamycin RTU 10 mg Injection

Adriamycin RTU 10 mg Injection is an essential chemotherapy agent utilized in combination with other medications to combat various malignancies, including bladder, breast, lung, stomach, and ovarian cancers, as well as both Hodgkins and non-Hodgkins lymphoma. This powerful injection works by disrupting the growth of cancer cells, ultimately leading to their destruction and reducing tumor size. It is also effective in treating specific types of leukemia, such as acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Patients receiving Adriamycin should be aware of potential side effects, including increased risk of infections, heart problems, and gastrointestinal issues, making close monitoring essential during treatment. It is crucial to inform healthcare providers about any pre-existing conditions and current medications to avoid interactions. As part of a comprehensive cancer treatment plan, Adriamycin RTU plays a vital role in improving patient outcomes. Always consult your healthcare professional for personalized advice and to understand the complete risk-benefit profile of this chemotherapy option.

Trusted Oncology Solution

Adriamycin RTU 10 mg Injection provides a dependable and precise treatment option for cancer patients. Its liquid form allows for accurate dosing, while the Indian origin ensures strict quality standards. With ABIRATERONE ACETATE as its main ingredient, this injection is recommended for adult use in clinical settings, ensuring safe and effective administration.


Professional Distribution and Usage

Exclusively supplied to doctors, distributors, exporters, suppliers, traders, and wholesalers, Adriamycin RTU 10 mg Injection is ideal for professional healthcare environments. The standard packaging of 175 pieces ensures consistent supply for medical institutions and supports streamlined treatment processes. Always follow physician guidance for optimal results.